Published by Josh White on 2nd December 2022
(Sharecast News) - Ondine Biomedical reported full results from its phase two 'BENEFIT-PDT' clinical trial on Friday, which met its primary endpoint of bacterial load reduction after nasal photodisinfection.
URL: http://www.digitallook.com/dl/news/story/33151647/...